Seeking Alpha

Pernix (PTX +4.2%) unit Hawthorn receives FDA approval for its Vitus drug for treating adults...

Pernix (PTX +4.2%) unit Hawthorn receives FDA approval for its Vitus drug for treating adults with coughs, colds and symptoms associated with upper respiratory allergies. Pernix's Cypress receives approval for a generic version of Ponstel Capsules for pain relief and treating primary dysmenorrhea (cramp in the lower abdomen in women). (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs